AAAAAA

   
Results: 1-22 |
Results: 22

Authors: Silva, JM Dominguez, G Silva, J Garcia, JM Sanchez, A Rodriguez, O Provencio, M Espana, P Bonilla, F
Citation: Jm. Silva et al., Detection of epithelial messenger RNA in the plasma of breast cancer patients is associated with poor prognosis tumor characteristics, CLIN CANC R, 7(9), 2001, pp. 2821-2825

Authors: Dominguez, C Silva, J Silva, JM Garcia, JM Larrondo, FJ Vargas, J Sanfrutos, L Provencio, M Espana, P Bonilla, F
Citation: C. Dominguez et al., Different expression of P14ARF defines two groups of breast carcinomas in terms of TP73 expression and TP53 mutational status, GENE CHROM, 31(2), 2001, pp. 99-106

Authors: Provencio, M Espana, P Salas, C Sanchez, A Bonilla, F
Citation: M. Provencio et al., Hodgkin's disease: Unsuspected minimal activity in patients that die from causes other than tumoral progression, LEUK LYMPH, 42(4), 2001, pp. 661-664

Authors: Silva, J Dominguez, G Silva, JM Garcia, JM Gallego, I Corbacho, C Provencio, M Espana, P Bonilla, F
Citation: J. Silva et al., Analysis of genetic and epigenetic processes that influence p14ARF expression in breast cancer, ONCOGENE, 20(33), 2001, pp. 4586-4590

Authors: Cutuli, B Borel, C Dhermain, F Magrini, SM Wasserman, TH Bogart, JA Provencio, M de Lafontan, B de la Rochefordiere, A Cellai, E Graic, Y Kerbrat, P Alzieu, C Teissier, E Dilhuydy, JM Mignotte, H Velten, M
Citation: B. Cutuli et al., Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases, RADIOTH ONC, 59(3), 2001, pp. 247-255

Authors: Dominguez, G Silva, JM Silva, J Garcia, JM Sanchez, A Navarro, A Gallego, I Provencio, M Espana, P Bonilla, F
Citation: G. Dominguez et al., Wild type p73 overexpression and high-grade malignancy in breast cancer, BREAST CANC, 66(3), 2001, pp. 183-190

Authors: Silva, JM Garcia, JM Dominguez, G Silva, J Rodriguez, R Portero, JL Corbacho, C Provencio, M Espana, P Bonilla, F
Citation: Jm. Silva et al., DNA damage after chemotherapy correlates with tumor response and survival in small cell lung cancer patients, MUT RES-F M, 456(1-2), 2000, pp. 65-71

Authors: Silva, J Silva, JM Dominguez, G Garcia, JM Rodriguez, O Garcia-Andrade, C Cuevas, J Provencio, M Espana, P Bonilla, F
Citation: J. Silva et al., Absence of point mutations at codon 17 of the Mdm2 gene (serine 17) in human primary tumors, MUT RES-F M, 449(1-2), 2000, pp. 41-45

Authors: Gonzalez, R Silva, JM Sanchez, A Dominguez, G Garcia, JM Chen, XQ Stroun, M Provencio, M Espana, P Anker, P Bonilla, F
Citation: R. Gonzalez et al., Microsatellite alterations and TP53 mutations in plasma DNA of small-cell lung cancer patients: Follow-up study and prognostic significance, ANN ONCOL, 11(9), 2000, pp. 1097-1104

Authors: Provencio, M Espana, P Salas, C Navarro, F Bonilla, F
Citation: M. Provencio et al., Hodgkin's disease: Correlation between causes of death at autopsy and clinical diagnosis, ANN ONCOL, 11(1), 2000, pp. 59-64

Authors: Villanueva, MJ Navarro, F Sanchez, A Provencio, M Bonilla, F Espana, P
Citation: Mj. Villanueva et al., Testicular germ cell tumor and Down syndrome, TUMORI, 86(5), 2000, pp. 431-433

Authors: Navarro, F Vicente, J Villanueva, MJ Sanchez, A Provencio, M Espana, P
Citation: F. Navarro et al., Metastatic renal cell carcinoma to the head and neck area, TUMORI, 86(1), 2000, pp. 88-90

Authors: Dominguez, G Silva, J Silva, JM Garcia, JM Miralles, C Rodriguez, O Jareno, E Provencio, M Espana, P Bonilla, F
Citation: G. Dominguez et al., Clinicopathological characteristics of breast carcinomas with allelic lossin the p73 region, BREAST CANC, 63(1), 2000, pp. 17-22

Authors: Provencio, M Garcia-Lopez, FJ Bonilla, F Espana, P
Citation: M. Provencio et al., Comparison of the long-term mortality in Hodgkin's disease patients with that of the general population, ANN ONCOL, 10(10), 1999, pp. 1199-1205

Authors: Lobo, F Frau, A Barnadas, A Mendez, M Lizon, J Provencio, M Albistur, JJ Martinez, P Sanchez, MJ Constenla, M Estevez, LG
Citation: F. Lobo et al., Phase II study of ifosfamide plus vinorelbine in metastatic breast cancer patients previously treated with combination chemotherapy, CANC CHEMOT, 44, 1999, pp. S5-S8

Authors: Garcia, JM Silva, JM Dominguez, G Gonzalez, R Navarro, A Carretero, L Provencio, M Espana, P Bonilla, F
Citation: Jm. Garcia et al., Allelic loss of the PTEN region (10q23) in breast carcinomas of poor pathophenotype, BREAST CANC, 57(3), 1999, pp. 237-243

Authors: Silva, JM Gonzalez, R Provencio, M Dominguez, G Garcia, JM Gallego, I Palacios, J Espana, P Bonilla, F
Citation: Jm. Silva et al., Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer, BREAST CANC, 53(1), 1999, pp. 9-17

Authors: Gomendio, B Silva, JM Garcia, JM Provencio, M Espana, P Bonilla, F
Citation: B. Gomendio et al., Low incidence of germline BRCA2 gene mutations among Spanish breast cancerpatients, ONCOL-BASEL, 57(2), 1999, pp. 173-174

Authors: Villanueva, MJ Navarro, E Sanchez, A Provencio, M
Citation: Mj. Villanueva et al., Coexistence of breast cystosarcoma phyllodes and bilateral in situ lobularcarcinoma, REV CLIN ES, 199(11), 1999, pp. 776-776

Authors: Silva, JM Dominguez, G Garcia, JM Gonzalez, R Villanueva, MJ Navarro, F Provencio, M San Martin, S Espana, P Bonilla, F
Citation: Jm. Silva et al., Presence of tumor DNA in plasma of breast cancer patients: Clinicopathological correlations, CANCER RES, 59(13), 1999, pp. 3251-3256

Authors: Gonzalez, R Silva, JM Dominguez, G Garcia, JM Martinez, G Vargas, J Provencio, M Espana, P Bonilla, F
Citation: R. Gonzalez et al., Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations, BR J CANC, 81(3), 1999, pp. 503-509

Authors: Silva, JM Dominguez, G Villanueva, MJ Gonzalez, R Garcia, JM Corbacho, C Provencio, M Espana, P Bonilla, F
Citation: Jm. Silva et al., Aberrant DNA methylation of the p16(INK4a) gene in plasma DNA of breast cancer patients, BR J CANC, 80(8), 1999, pp. 1262-1264
Risultati: 1-22 |